Repare Therapeutics (RPTX) Financials

$2.65

$0.00 (0.00%)

As on 28-Jan-2026 09:30EDT

Market cap

$114 Mln

Revenue (TTM)

$-42 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	-41.61	53.48	51.13	131.83	7.60	0.14
Cost of Revenue	2.75	13.38	13.24	116.72	87.85	38.78
Gross Profit	2.73	40.10	37.89	15.11	-80.25	-38.64
Operating Expenses	77.82	133.62	154.12	34.90	28.41	15.66
Operating Profit (EBIT)	-75.09	-93.52	-116.22	-19.80	-108.66	-54.30
Other Income	--	--	--	--	0.07	-0.44
Profit before Tax	-71.16	-83.25	-103.18	-13.90	-108.59	-54.74
Provision for Tax	1.04	1.44	-9.38	15.15	-1.68	-1.33
Profit after Tax (Net Income)	-72.20	-84.69	-93.80	-29.05	-106.91	-53.42
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-29.05	-106.91	-53.42

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	115.13	151.13	212.08	279.52	288.42	286.83
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.09	2.74	5.94	45.21	59.24
Current Liabilities	11.62	25.29	39.08	78.62	35.09	11.01
Total Liabilities	138.37	176.51	253.90	364.08	368.72	357.09

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	2.32	5.36	10.21	10.10	17.30	10.53
Current Assets	124.43	171.15	243.69	353.98	351.41	346.55
Total Assets	138.37	176.51	253.90	364.08	368.72	357.09
Total Debt*	0.34	1.93	3.41	5.43	7.31	4.01
Net Current Assets	112.81	145.86	204.61	275.36	316.33	335.54

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-76.45	-127.16	0.32	-85.80	-6.08
Cash Flow from Investing Activities	--	49.47	78.04	-175.78	-1.68	-9.76
Cash from Financing Activities	--	0.54	0.84	0.88	95.56	247.84
Net Cash Inflow / Outflow	--	--	--	--	8.09	232.00

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.70	-2.00	-2.23	-0.69	-2.66	-1.45
Cash EPS ($)	--	-1.95	-2.18	-0.64	-2.62	-1.43
Adjusted Book Value ($)	--	3.56	5.03	6.65	7.18	7.80
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.80	-3.02	0.01	-2.14	-0.17
Free Cash Flow per Share ($)	--	-1.80	-3.06	-0.01	-2.18	-0.23

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-45.96	-37.49	-10.00	-36.45	-27.98
ROE (%)	-60.11	-46.63	-38.16	-10.23	-37.17	-28.36
ROA (%)	-38.42	-39.35	-30.36	-7.93	-29.46	-23.24
EBIT Margin (%)	188.82	-172.31	-227.30	-15.02	-1,429.74	-40,223.70
Net Margin (%)	173.53	-158.37	-183.44	-22.03	-1,393.12	17,513.77
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-134.67	0.05	-0.61	16.35	55.30	--
EBIT Growth (%)	7.01	20.72	-487.11	81.78	-100.10	-105.26
Net Profit Growth (%)	14.10	9.71	-222.91	72.83	-100.14	-96.27
EPS Growth (%)	15.04	0.10	-2.22	0.74	-0.83	-0.24
Book Value Growth (%)	-35.11	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.66	-3.28	-21.29	-7.92	-23.62
Price / Book Value	0.99	0.37	1.45	2.21	2.94	4.40
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.58	1.06	-0.76	-15.71	-4.78	-17.45
Close Price ($)	1.76	1.31	7.30	14.71	21.09	34.30
High Price ($)	4.07	8.49	15.38	22.20	46.44	40.00
Low Price ($)	0.89	1.20	3.08	8.07	18.38	21.45
Market Cap ($ Cr)	114.24	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.01	0.02	0.02	0.03	0.01
Short term debt to equity ratio	0.00	0.01	0.01	0.01	0.01	0.00
Current Ratio	10.71	6.77	6.24	4.50	10.01	31.46
Quick Ratio	10.71	--	6.24	4.54	--	--
Interest Coverage	--	--	--	-2.42	-77.56	-262.33

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	-15.59	23.09	29.95	3.28	42.55	4,565.93
Asset Turnover	-0.22	0.25	0.17	0.36	0.02	0.00
Receivable days	--	94.45	70.13	10.47	225.83	12,472.61
Inventory Days	--	0.00	-38.69	-8.78	--	--
Payable days	--	82.22	39.47	4.32	9.46	20.62
Cash Conversion Cycle	--	12.23	-8.03	-2.63	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.